1.08
price down icon2.26%   -0.025
after-market Handel nachbörslich: 1.06 -0.02 -1.85%
loading
Schlusskurs vom Vortag:
$1.105
Offen:
$1.1
24-Stunden-Volumen:
12,118
Relative Volume:
0.33
Marktkapitalisierung:
$12.50M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-2.0377
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
-3.57%
1M Leistung:
-1.82%
6M Leistung:
+24.14%
1J Leistung:
-38.53%
1-Tages-Spanne:
Value
$1.06
$1.10
1-Wochen-Bereich:
Value
$1.05
$1.1299
52-Wochen-Spanne:
Value
$0.70
$2.44

Therapeuticsmd Inc Stock (TXMD) Company Profile

Name
Firmenname
Therapeuticsmd Inc
Name
Telefon
561-961-1900
Name
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Name
Mitarbeiter
1
Name
Twitter
@TherapeuticsMD
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
TXMD's Discussions on Twitter

Vergleichen Sie TXMD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
TXMD
Therapeuticsmd Inc
1.08 12.27M 996.00K -6.09M -9.76M -0.53
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.20 67.75B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.29 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.84 43.70B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.48 21.51B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
380.47 18.31B 2.99B 1.21B 1.13B 25.06

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-08-07 Herabstufung Jefferies Hold → Underperform
2020-05-19 Herabstufung JP Morgan Overweight → Neutral
2019-12-02 Eingeleitet Guggenheim Buy
2019-10-17 Eingeleitet H.C. Wainwright Buy
2019-04-30 Fortgesetzt Noble Capital Markets Outperform
2018-06-15 Eingeleitet JP Morgan Overweight
2017-09-08 Eingeleitet Morgan Stanley Equal-Weight
2017-07-11 Hochstufung Oppenheimer Perform → Outperform
2017-05-09 Herabstufung Oppenheimer Outperform → Perform
2016-11-22 Fortgesetzt Jefferies Buy
2016-11-22 Eingeleitet Oppenheimer Outperform
2016-11-07 Fortgesetzt Guggenheim Buy
2016-04-04 Eingeleitet Goldman Buy
2015-12-08 Bestätigt Jefferies Buy
2015-12-08 Bestätigt Stifel Buy
2015-09-21 Bestätigt Jefferies Buy
2015-06-09 Eingeleitet Guggenheim Buy
2014-07-08 Eingeleitet FBR Capital Outperform
2014-04-17 Bestätigt Noble Financial Buy
2014-01-28 Bestätigt Noble Financial Buy
Alle ansehen

Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten

pulisher
Sep 03, 2025

How to build a custom watchlist for TherapeuticsMD Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What technical models suggest about TherapeuticsMD Inc.’s comebackWall Street Watch & Weekly Top Stock Performers List - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

TherapeuticsMD Inc. stock volume spike explainedMarket Movers & Fast Entry Momentum Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Has TherapeuticsMD Inc. found a price floor2025 EndofYear Setup & Weekly Market Pulse Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What’s the recovery path for long term holders of TherapeuticsMD Inc.Dollar Strength & Real-Time Buy Signal Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What drives TherapeuticsMD Inc.’s stock priceJuly 2025 Gainers & Smart Swing Trading Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

When is the best time to exit TherapeuticsMD Inc.2025 Historical Comparison & Reliable Trade Execution Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will TherapeuticsMD Inc. stock recover after recent dropDividend Hike & Safe Capital Growth Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Visual analytics tools that track TherapeuticsMD Inc. performanceEntry Point & Precise Buy Zone Identification - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Long term hold vs stop loss in TherapeuticsMD Inc.July 2025 Fed Impact & High Conviction Investment Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will TherapeuticsMD Inc. outperform the marketWeekly Market Outlook & Verified Swing Trading Watchlists - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Chart based exit strategy for TherapeuticsMD Inc.Trade Risk Assessment & Community Verified Trade Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to escape a deep drawdown in TherapeuticsMD Inc.Weekly Profit Analysis & Expert Curated Trade Setup Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

TherapeuticsMD Inc. stock trend outlook and recovery pathMarket Activity Recap & Verified Entry Point Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Historical volatility pattern of TherapeuticsMD Inc. visualizedQuarterly Earnings Report & Real-Time Volume Trigger Notifications - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Advanced analytics toolkit walkthrough for TherapeuticsMD Inc.Market Risk Summary & Daily Chart Pattern Signals - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Identifying reversal signals in TherapeuticsMD Inc.CEO Change & Weekly Return Optimization Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛

Sep 02, 2025
pulisher
Sep 02, 2025

Will TherapeuticsMD Inc. continue its uptrendQuarterly Trade Report & Precise Swing Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Should value investors consider TherapeuticsMD Inc.2025 Risk Factors & Fast Gain Swing Alerts - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Risk vs reward if holding onto TherapeuticsMD Inc.Quarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Does TherapeuticsMD Inc. stock benefit from AI growthQuarterly Earnings Report & Free Community Consensus Stock Picks - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is TherapeuticsMD Inc. a candidate for recovery playJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How to use Fibonacci retracement on TherapeuticsMD Inc.July 2025 Action & Precise Swing Trade Entry Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Should you wait for a breakout in TherapeuticsMD Inc.July 2025 Technicals & Expert Curated Trade Setup Alerts - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Nasdaq Moves: Does TherapeuticsMD Inc. stock benefit from AI growthMarket Activity Summary & Low Drawdown Investment Strategies - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Screener Results Flag TherapeuticsMD Inc. as Oversold getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 01, 2025
pulisher
Sep 01, 2025

Is TherapeuticsMD Inc. part of any major indexEarnings Growth Summary & Technical Buy Zone Confirmation - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

What recovery options are there for TherapeuticsMD Inc.July 2025 Selloffs & Technical Entry and Exit Alerts - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

TherapeuticsMD Inc. stock trend forecastTrend Reversal & Reliable Trade Execution Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to track smart money flows in TherapeuticsMD Inc.2025 Market Overview & Long-Term Growth Stock Strategies - Newser

Aug 31, 2025

Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Therapeuticsmd Inc-Aktie (TXMD) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Walker Marlan D
Chief Executive Officer
Apr 14 '25
Buy
1.00
490
489
73,639
Walker Marlan D
Chief Executive Officer
Apr 10 '25
Buy
0.86
1,167
1,000
73,149
Walker Marlan D
Chief Executive Officer
Apr 09 '25
Buy
0.87
1,136
994
71,982
Collins Cooper C.
Director
Feb 18 '25
Option Exercise
0.00
8,500
0
60,516
Naughton Gail K
Director
Feb 18 '25
Option Exercise
0.00
8,500
0
8,500
Thompson Tommy G
Director
Feb 18 '25
Option Exercise
0.00
8,500
0
14,454
Walker Marlan D
Chief Executive Officer
Feb 18 '25
Option Exercise
0.00
8,281
0
70,846
$28.92
price down icon 3.60%
$17.47
price up icon 0.69%
drug_manufacturers_specialty_generic RDY
$14.15
price down icon 0.28%
$10.33
price down icon 2.09%
$140.40
price up icon 3.15%
$380.47
price down icon 2.80%
Kapitalisierung:     |  Volumen (24h):